Joseph L. Goldstein - 07 Jun 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: Director
Signature: /s/**Joseph L. Goldstein
Issuer symbol: REGN
Transactions as of: 07 Jun 2021
Net transactions value: -$291,198
Form type: 4
Filing time: 08 Jun 2021, 16:03:08 UTC
Next filing: 13 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Options Exercise	$722,052	+1,930	+33%	$374.12	7,821	07 Jun 2021	Direct	F1
transaction	REGN	Common Stock	Sale	$1,013,250	-1,930	-25%	$525.00	5,891	07 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REGN	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-1,930	-44%	$0.000000	2,431	07 Jun 2021	Common Stock	1,930	$374.12	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2	On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.